These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 25085644)

  • 1. CKD and nonalcoholic fatty liver disease.
    Targher G; Chonchol MB; Byrne CD
    Am J Kidney Dis; 2014 Oct; 64(4):638-52. PubMed ID: 25085644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
    Targher G; Chonchol M; Zoppini G; Abaterusso C; Bonora E
    J Hepatol; 2011 May; 54(5):1020-9. PubMed ID: 21145850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.
    Vanni E; Marengo A; Mezzabotta L; Bugianesi E
    Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.
    Targher G; Byrne CD
    Nat Rev Nephrol; 2017 May; 13(5):297-310. PubMed ID: 28218263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration.
    Hamad AA; Khalil AA; Connolly V; Ahmed MH
    Arab J Gastroenterol; 2012 Dec; 13(4):161-5. PubMed ID: 23432982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
    Ahmed MH; Ali A
    Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.
    Zeng J; Sun C; Sun WL; Chen GY; Pan Q; Yan SY; Xu ZJ; Chen YW; Fan JG
    J Dig Dis; 2017 Apr; 18(4):229-236. PubMed ID: 28296249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.
    Jang HR; Kang D; Sinn DH; Gu S; Cho SJ; Lee JE; Huh W; Paik SW; Ryu S; Chang Y; Shafi T; Lazo M; Guallar E; Cho J; Gwak GY
    Sci Rep; 2018 Mar; 8(1):4718. PubMed ID: 29549269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.
    Targher G; Byrne CD
    Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
    Paik J; Golabi P; Younoszai Z; Mishra A; Trimble G; Younossi ZM
    Liver Int; 2019 Feb; 39(2):342-352. PubMed ID: 30347513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
    Lonardo A; Ballestri S; Marchesini G; Angulo P; Loria P
    Dig Liver Dis; 2015 Mar; 47(3):181-90. PubMed ID: 25739820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.
    Choudhary NS; Saraf N; Kumar N; Rai R; Saigal S; Gautam D; Lipi L; Rastogi A; Goja S; Bhangui P; Ramchandra SK; Soin AS
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):441-3. PubMed ID: 26636408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study.
    Jung CY; Chun HS; Lee M; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
    Diabetes Metab; 2022 Sep; 48(5):101362. PubMed ID: 35660527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.